Is screening for breast cancer with mammography justifiable?

Lancet

Volumn 355, Issue 9198, 2000, Pages 129-134

  Gøtzsche, Peter C ^a   Olsen, Ole ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAMMOGRAPHY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN;

EID: 0034620242     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)06065-1     Document Type: Article

References (45)

1. Dickersin K. Breast screening in women aged 40-49 years: what next? Lancet. 353:1999;1896-1897.
2. Chu K.C., Smart C.R., Tarone R.E. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst. 80:1988;1125-1132.
3. Alexander F.E., Anderson T.J., Brown H.K.et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 353:1999;1903-1908.
4. Miller A.B., Baines C.J., To T., Wall C. Canadian National Breast Screening Study: 1-breast cancer detection and death rates among women aged 40-49 years. Can Med Assoc J. 147:1992;1459-1476.
5. Miller A.B., Baines C.J., To T., Wall C. Canadian National Breast Screening Study: 2-breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J. 147:1992;1477-1488.
6. Andersson I., Aspegren K., Janzon L.et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 297:1988;943-948.
7. Tabar L., Fagerberg G., Chen H.H.et al. Efficacy of breast cancer screening by age: new results from the Swedish Two-county Trial. Cancer. 75:1995;2507-2517.
8. Frisell J., Lidbrink E., Hellstrom L., Rutqvist L.E. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat. 45:1997;263-270.
9. Bjurstam N., Bjorneld L., Duffy S.W.et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 80:1997;2091-2099.
10. Nystrom L., Rutqvist L.E., Walls S.et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 341:1993;973-978.
11. Sjönell G., Ståhle L. Hålsokontroller med mammografi minskar inte dödlighet i bröstcancer. Läkartidningen. 96:1999;904-913.
12. Rehnqvist N., Rosén M., Karlberg I. Analys av dödligheten kräver helt annan metodik. Läkartidningen. 96:1999;1050-1051.
13. Rutqvist L.E. Naturalförloppet, grova metoder ledde till felkalkyl om böstcancer. Läkartidningen. 96:1999;1210-1211.
14. Schulz K.F., Chalmers I., Hayes R.J.et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412.
15. Moher D., Pham B., Jones A.et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 352:1998;609-613.
16. Shapiro S., Venet W., Strax P., Venet L. Periodic screening for breast cancer. 1998;Johns Hopkins University Press, Baltimore.
17. Shapiro S., Strax P., Venet L. Evaluation of periodic breast cancer screening with mammography: methodology and early observations. JAMA. 195:1966;731-738.
18. Fink R., Shapiro S., Roester R. Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Publ Health. 62:1972;328-336.
19. Aron J.L., Prorok P.C. An analysis of the mortality effect in a breast cancer screening study. Int J Epidemiol. 15:1986;36-43.
20. Shapiro S. Screening: assessment of current studies. Cancer. 74:1994;231-238.
21. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 39:1977;2772-2782.
22. Alexander F.E., Anderson T.J., Brown H.K.et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer. 70:1994;542-548.
23. Roberts M.M., Alexander F.E., Anderson T.J.et al. The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer. 50:1984;1-6.
24. Miller A.B., Howe G.R., Wall C. The National Study of Breast Cancer Screening Protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med. 4:1981;227-258.
25. Bailar I.J.C., MacMahon B., Phillips R.A. Randomization in the Canadian National Breast Screening Study; a review for evidence of subversion. Can Med Assoc J. 156:1997;193-199.
26. Baines C.J. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med. 120:1994;326-334.
27. Miller A.B., To T., Baines C.J., Wall C. The Canadian national breast screening study: update on breast cancer mortality. J Natl Cancer Inst Monogr. 22:1997;37-41.
28. Andersson I., Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmö mammographic screening program. J Natl Cancer Inst Monogr. 22:1997;63-67.
29. Frisell J., Glas U., Hellstrom L., Somell A. Randomized mammographic screening or breast cancer in Stockholm: design, first round results and comparisons. Breast Cancer Res Treat. 8:1986;45-54.
30. Frinsell J., Eklung G., Hellstrom L., Lidbrink E., Rutqvist L.E., Sonnell A. Randomised study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 18:1991;49-56.
31. Tabar L., Gad A., Holmberg L. Reduction in advanced breast cancer: results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med. 54:1984;158-164.
32. Tabar L., Fagerberg C.J., Gad A.et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. i:1985;829-832.
33. Fagerberg G., Baldetorp L., Gontoft O., Lundstrom B., Manson J.C., Nordenskjold B. Effects of repeated mammographic screening on breast cancer stage distribution: results from a randomised study of 92 934 women in a Swedish county. Acta Radiol Oncol. 24:1985;465-473.
34. Tabar L., Fagerberg G., Duffy S.W., Day N.E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health. 43:1989;107-114.
35. Nystrom L., Larsson L.G., Wall S.et al. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts. J Med Screening. 3:1996;85-87.
36. Skrabanek P. Breast cancer screening with mammography. Lancet. 341:1993;1531.
37. Nyström L., Larsson L-G. Breast cancer screening with mammography. Lancet. 341:1993;1531-1532.
38. Swift M. Screening mammography. Lancet. 342:1993;549-550.
39. Nyström L., Larsson L-G. Screening mammography. Lancet. 342:1993;550-551.
40. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 20:1991;47-63.
41. Hulley S., Grady D., Bush T.et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.
42. Semiglazov V.F., Moiseenko V.M., Protsenko S.A.et al. Promezhutochnye rezul'taty programmy Rocciia (Santkt-Peterburg)/VOZ po otsenke effektivnosti samoobsledovaniia molochnykh zhelez (Preliminary results of the Russia (St Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination.). Vopr Onkol. 42:1996;49-55.
43. Kerlikowske K. Efficacy of screening mammography: a meta-analysis. JAMA. 273:1995;149-154.
44. Narod S.A. On being the right size: reappraisal of mammography trials in Canada and Sweden. Lancet. 349:1997;1869.
45. Elmore J.G., Barton M.B., Moceri V.M.et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 338:1998;1089-1096.